The Patent Finder
US

Directional Laser Probe

US 7,402,158 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Dec 21, 2020 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Aug 17, 2005 as application 11/205,936 · Granted Jul 22, 2008
Base term plus 258 days of patent term adjustment (USPTO delay)
Today
20 years from filing
Term ended Dec 21, 2020
2000 2026
Clock starts
Apr 7, 2000
Term ended
Dec 21, 2020
Granted
Jul 22, 2008
base term patent term adjustment after the term ends fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
258
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
24
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 258 days past its 20-year base term on prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 7, 2000, when application 09/545,143, the earliest non-provisional in its chain, was filed (this one was filed Aug 17, 2005); a parent in its chain could not be resolved (the next row)Apr 7, 2020High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+258 days, USPTO patent term adjustment recordDec 21, 2020High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderDec 21, 2020Medium confidence

This family

US 6,772,765Term ended
Jul 2022
Jul 2022
US 6,984,230Term ended
Apr 2020
Apr 2020
US 7,470,269Term ended
Jul 2025
Jul 2025
Application PCT/US2004/009115PCT application
no patent term
no patent term
US 8,241,321In force
Feb 2030
Feb 2030
Application PCT/US2004/038176PCT application
no patent term
no patent term
Application PCT/US2004/038175PCT application
no patent term
no patent term
US 7,402,158this patent
Dec 2020
Dec 2020
8 of 24 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

The 40 most recent of 43 recorded documents are shown; the 3 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 21, 2015
Reel 37357, frame 490
Sprout Pharmaceuticals, Inc., as Grantor; Unilens Vision Inc., as Grantor; Commonwealth Laboratories, LLC, as Grantor; Synergetics USA, Inc., as GrantorBarclays Bank PLC, as Collateral AgentSecurity Agreement
Mar 11, 2019
Reel 48556, frame 758
Bausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Interest
Apr 8, 2025
Reel 70778, frame 199
Barclays Bank PLC, as Collateral AgentSolta Medical, Inc.; Precision Dermatology, Inc.; Bausch Health Ireland Limited (F/K/A/ Valeant Pharmaceuticals Ireland Limited); Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Medicis Pharmaceutical Corporation; Humax Pharmaceutical S.A.; Solta Medical Ireland Limited; Bausch & Lomb Mexico, S.A. de C.V.; Bausch+lomb Ops B.V.; Bausch Health Americas, Inc.; Bausch Health Companies Inc.; Bausch Health Holdco Limited; Bausch Health Magyarorszag KFT (A/K/A Bausch Health Hungary LLC); Bausch Health Poland Spolka Z Ograniczona Odpowiedzialnoscia (F/K/A Valeant Pharma Poland Spolka Z Ograniczona Odpowiedzialnoscia); Bausch Health US, LLC; Bausch Health, Canada Inc. / Sante Bausch, Canada Inc.; ICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.); Orapharma, Inc.; Przedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.); Solta Medical Dutch Holdings B.V.; V-Bac Holding Corp.; VRX Holdco LLC; 1261229 B.C. Ltd.; 1530065 B.C. Ltd.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentSolta Medical, Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentPrecision Dermatology, Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health Ireland Limited (F/K/A/ Valeant Pharmaceuticals Ireland Limited)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentSalix Pharmaceuticals, Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentSalix Pharmaceuticals, Ltd.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentSantarus, Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentMedicis Pharmaceutical CorporationRelease of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentHumax Pharmaceutical S.A.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentSolta Medical Ireland LimitedRelease of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch & Lomb Mexico, S.A. de C.V.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch+lomb Ops B.V.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health Americas, Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health Companies Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health Holdco LimitedRelease of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health Magyarorszag KFT (A/K/A Bausch Health Hungary LLC)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health Poland Spolka Z Ograniczona Odpowiedzialnoscia (F/K/A Valeant Pharma Poland Spolka Z Ograniczona Odpowiedzialnoscia)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health US, LLCRelease of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health, Canada Inc. / Sante Bausch, Canada Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentOrapharma, Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentPrzedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentSolta Medical Dutch Holdings B.V.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentV-Bac Holding Corp.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentVRX Holdco LLCRelease of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral Agent1261229 B.C. Ltd.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral Agent1530065 B.C. Ltd.Release of Security Interest
Nov 20, 2025
Reel 73637, frame 126
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb IncorporatedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health US, LLCRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentMedicis Pharmaceutical CorporationRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Ltd.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSantarus, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentOrapharma, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentPrecision Dermatology, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited